CLINICAL_TRIALS ClinicalTrials.gov record update

A Post-market Registry of the BioMatrix Alpha TM (Cobalt Chromium Biolimus A9TM (BA9TM) Drug-eluting Stent)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02871622
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:08.578137+00:00
Published At: 2016-08-18T00:00:00+00:00
Record Updated At: 2016-08-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Coronary Artery Disease", "Stable Angina", "Ischemia", "Acute Coronary Syndrome", "NSTEMI", "STEMI"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-08-18"
protocolSection.identificationModule.nctId: "NCT02871622"
protocolSection.identificationModule.officialTitle: "A Post-market Registry of the BioMatrix Alpha TM (Cobalt Chromium Biolimus A9TM (BA9TM) Drug-eluting Stent)"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.